A Study of IW-6463 in Healthy Volunteers

Other Clinical Trial

Official title:
A Phase 1 Study Evaluating the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics of IW-6463 When Administered to Healthy Volunteers as Single Ascending Doses, as Multiple Ascending Doses, and Under Fed Versus Fasting Conditions

Status Completed

Clinical Trial Summary

Stage 1: To assess the safety and tolerability of single-ascending-dose levels of IW-6463 tablets when administered orally to healthy subjects Stage 2: To assess the safety and tolerability of multiple-ascending-dose levels of IW-6463 tablets administered orally to healthy subjects Stage 3: To assess the safety and tolerability of a single dose of IW-6463 when administered to health subjects in fed vs fasted states and explore the effects of food on IW-6463 pharmacokinetics (PK)

Clinical Trial Description

n/a

Study Design

Related Conditions & MeSH terms

Other

Clinical Trial Details

NCT number	NCT03856827
Study type	Interventional
Source	Tisento Therapeutics
Contact
Status	Completed
Phase	Phase 1
Start date	February 6, 2019
Completion date	October 22, 2019

View Details

See also
Status	Clinical Trial	Phase
Completed	`NCT03489187` - Visualase Visualization Database (VIVID-1)
Completed	`NCT06312449` - Effect of Peanut Balls Used of the Second Stage of Labor, Pushing Perceptions, Fatigue and Birth Outcomes	N/A
Completed	`NCT03775694` - Diffusion MRI-1 Imaging Database
Recruiting	`NCT00840047` - Methionine PET/CT Studies In Patients With Cancer	Phase 2
Completed	`NCT04236921` - Bioequivalence Bewteen DopaSnap® (Cabidopa/Levopdoap 25/100 mg Tablet) and Carbidopa/Levodopa 25/100 mg Tablet (Actavis)	Phase 1
Terminated	`NCT04240158` - IW-6463 Safety Study in Healthy Elderly Subjects	Phase 1
Recruiting	`NCT06336980` - Creating Welcoming Faith Communities for People With Serious Mental Illnesses	N/A
No longer available	`NCT03723083` - Expanded Access for CC-2001